Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Colonic Neoplasms

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Colonic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awrey, DE; Ban, F; Beletskaya, I; Bray, MR; Che, Y; Chirgadze, NY; Edwards, L; Feher, M; Fletcher, GC; Forrest, B; Hodgson, R; Kiarash, R; Lang, Y; Laufer, R; Li, SW; Lin, DC; Liu, Y; Madeira, B; Mak, TW; Mao, G; Mason, JM; Ng, G; Patel, NK; Pauls, HW; Plotnikova, O; Qiu, W; Sampson, PB; Wei, X1
Abassi, Y; Daams, R; Fezai, M; JemaĆ , M; Kifagi, C; Lang, F; Massoumi, R1
Drag, M; Groborz, K; Poreba, M; Rut, W; Salvesen, GS; Snipas, SJ1

Other Studies

3 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Colonic Neoplasms

ArticleYear
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents.
    Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

    Topics: Administration, Oral; Animals; Cell Cycle Proteins; Cell Line, Tumor; Colon; Colonic Neoplasms; Crystallography, X-Ray; Female; Humans; Indazoles; Mice, Nude; Models, Molecular; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases

2015
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1.
    Scientific reports, 2018, 08-07, Volume: 8, Issue:1

    Topics: Animals; Anthracenes; Cell Line; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Humans; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase 8; Molecular Targeted Therapy; Morpholines; Purines; Tumor Burden; Xenograft Model Antitumor Assays

2018
Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells.
    Cell death and differentiation, 2019, Volume: 26, Issue:12

    Topics: Apoptosis; Caspase 2; Colonic Neoplasms; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; HCT116 Cells; Humans; Morpholines; Proto-Oncogene Proteins c-mdm2; Purines; Substrate Specificity

2019